Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis

[1] Cranney A(2006)Parathyroid hormone for the treatment of osteoporosis: a systematic review CMAJ 175 52-59

[2] Papaioannou A(2001)Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434-1441

[3] Zytaruk N(2006)Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis J Bone Miner Res 21 1785-1790

[4] Hanley D(2007)Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study J Bone Miner Res 22 1426-1433

[5] Adachi J(2009)Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study J Bone Miner Res 24 1672-1680

[6] Goltzman D(2010)Quantitative computed tomography assessment of the effects of 24 months of teriparatide treatment on 3-D femoral neck bone distribution, geometry and bone strength: results from the EUROFORS study J Bone Miner Res 25 472-481

[7] Murray T(2008)Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method Bone 42 1203-1213

[8] Hodsman A(2007)Effects of one year treatment with PTH(1-34) on bone microstructure at the ultradistal radius J Bone Miner Res 22 S24-337

[9] Neer RM(1998)In vivo high resolution 3D-QCT of the human forearm Technol Health Care 6 329-799

[10] Arnaud CD(2008)Improved reproducibility of high-resolution peripheral quantitative computed tomography for measurement of bone quality Med Eng Phys 30 792-515

[1] Cranney A(2006)Parathyroid hormone for the treatment of osteoporosis: a systematic review CMAJ 175 52-59

[2] Papaioannou A(2001)Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis N Engl J Med 344 1434-1441

[3] Zytaruk N(2006)Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis J Bone Miner Res 21 1785-1790

[4] Hanley D(2007)Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study J Bone Miner Res 22 1426-1433

[5] Adachi J(2009)Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study J Bone Miner Res 24 1672-1680

[6] Goltzman D(2010)Quantitative computed tomography assessment of the effects of 24 months of teriparatide treatment on 3-D femoral neck bone distribution, geometry and bone strength: results from the EUROFORS study J Bone Miner Res 25 472-481

[7] Murray T(2008)Bone strength at the distal radius can be estimated from high-resolution peripheral quantitative computed tomography and the finite element method Bone 42 1203-1213

[8] Hodsman A(2007)Effects of one year treatment with PTH(1-34) on bone microstructure at the ultradistal radius J Bone Miner Res 22 S24-337

[9] Neer RM(1998)In vivo high resolution 3D-QCT of the human forearm Technol Health Care 6 329-799

[10] Arnaud CD(2008)Improved reproducibility of high-resolution peripheral quantitative computed tomography for measurement of bone quality Med Eng Phys 30 792-515